The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
about
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapiesPituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling.Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawalPituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.Regulation of apoptosis by vasoactive peptides.AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts.PACAP modulation of calcium ion activity in developing granule cells of the neonatal mouse olfactory bulb.PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cellsTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neuronsPharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways.Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium ChannelsMultimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke modelsRas protein activation is a key event in activity-dependent survival of cerebellar granule neurons.PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation.Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation.PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP.Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis.Cyclic AMP-mediated regulation of transcription factor Lot1 expression in cerebellar granule cells.Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta.Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Signal via Phospholipase C Pathway to Block Apoptosis in Newborn Rat Retina.Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum.The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells.Biochemical characterization of a Caspase-3 far-red fluorescent probe for non-invasive optical imaging of neuronal apoptosis.PAC1-expressing structures of neural retina alter their PAC1 isoform splicing during postnatal development.
P2860
Q30372282-1F4A4BB3-CF0B-4650-A478-61BC00EDDC84Q33624771-4C5527A8-996C-4FF6-B377-ECD98DAF90A2Q33850713-9E9B3EC3-E8C6-42FC-BE87-7D27C1540D23Q34029443-E56C40FE-D713-493B-A54B-97BFA04DEA26Q34179881-AA3E509E-060A-4B64-A997-B84BF654C598Q34254935-6F3ACA08-3F6F-491D-A1F1-82A36D8911A1Q34310714-F306A1A8-BADF-4F08-A76F-0F0FA7FACAB2Q34369962-771BD120-3393-488F-A332-7E398C424714Q34614152-B629ACC5-A349-4208-B76B-6EB00A5E97D4Q35086350-2E891930-C885-4DC0-8F9D-0C35B669DE7EQ35184653-420A9B20-876D-4832-A691-F36F796242E4Q35295564-6433BFC9-00DF-417E-8AD6-F21C2BE51B79Q35667237-28705E0D-7EE2-4216-A7FA-D3CC50CD5DACQ36153216-6F69F692-6CB5-439F-8EB2-9391935D0A6AQ36268291-C670639C-85DD-4E7D-AA9D-DC730273A1E9Q36521972-2145A70D-BB74-4427-903D-35F2F4E993ABQ36832414-40FD3D9E-9628-43A3-AB9C-9C990AC195A6Q38282096-BC97329B-647A-4DBF-9305-7787D0901ADEQ38383460-1ED34271-33E1-4408-A4F7-EB1F68C1880DQ39003365-648B3205-0A05-4277-BA9F-B3977DA4CBBBQ39159132-97583BE5-1DE6-44B0-AF51-0BC308C3A349Q39340625-F6C24C49-E815-472C-9996-C3FDE235DF45Q39908827-A6CFB37E-AB58-440A-B16B-5E1EB6ADF6C2Q41900340-520D1B87-6E20-45DC-8996-D1C5DEB71BB1Q42502409-145D02CD-8447-404B-BD58-0E8615F7E915Q42870334-0366C614-82EC-467D-A6B3-E8F43283E70DQ44004718-096D1395-EAFE-4A7A-8E18-6914F35985D6Q44831617-810B0BA5-19CF-4B06-83D1-586FB1688B7EQ45817009-3D646EF1-0D61-4749-90BC-90F23FA5B205Q46630018-03DCADE7-2E0D-4536-ACFE-7B12724F05C3Q47597257-C1F920DC-77AB-40C5-8BAF-868EF5C59782Q48090932-7B31FBFA-3278-40D5-940A-CF7AEFE44CC6Q48177160-79A5AD09-386F-41C0-BE0C-A7699DF12448Q48222782-E7F5B0AD-0B3F-483C-95B6-C47FADBA185FQ48297819-1B57FD85-F48E-434C-9A49-2B4A0161194CQ48763774-F7D35A9D-C136-4438-9F02-19CBCCBA5D77Q50701918-69C764A1-6C11-4A13-B144-128780C9BC71
P2860
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The neuroprotective effect of ...... teine protease caspase-3/CPP32
@en
The neuroprotective effect of ...... eine protease caspase-3/CPP32.
@nl
type
label
The neuroprotective effect of ...... teine protease caspase-3/CPP32
@en
The neuroprotective effect of ...... eine protease caspase-3/CPP32.
@nl
prefLabel
The neuroprotective effect of ...... teine protease caspase-3/CPP32
@en
The neuroprotective effect of ...... eine protease caspase-3/CPP32.
@nl
P2093
P2860
P356
P1476
The neuroprotective effect of ...... teine protease caspase-3/CPP32
@en
P2093
Fontaine M
Fournier A
Gonzalez BJ
Pamantung TF
P2860
P304
13390-13395
P356
10.1073/PNAS.97.24.13390
P407
P577
2000-11-01T00:00:00Z